News

Should You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings?

Biotech giant Bristol-Myers Squibb Company (BMY) is scheduled to report second-quarter 2025 results on July 31, before market ...

Merck & Co's Earnings Outlook

Analysts estimate that Merck & Co will report an earnings per share (EPS) of $2.01. Investors in Merck & Co are eagerly ...

Josh Brown on Pfizer (PFE): ‘I Was Dead Wrong, There’s No Turnaround’

Pfizer Inc (NYSE:PFE) is one of the Top 10 Stocks Wall Street is Buzzing About These Days. Josh Brown, CEO of Ritholtz Wealth ...

Morgan Stanley Maintains a Hold on Pfizer (PFE)

Pfizer Inc. (NYSE:PFE) is one of the top low volatility healthcare stocks to buy now. On July 22, Morgan Stanley analyst Terence Flynn maintained a Hold rating on Pfizer Inc. (NYSE:PFE) and set a ...
24/7 Wall St. on MSN8h

4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return Potential

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.
Stockhead on MSN1h

Dr Boreham’s Crucible: Oncology-focused Qbiotics hopes to crawl through IPO ‘window of opportunity’

With Virgin shares holding nicely at cruising altitude, is now the right time for private oncology drug developer Qbiotics to ...